Association Between Glycated Haemoglobin and Serum Lipid Parameters in Patients With Type 2 Diabetes Mellitus: A Hospital-Based Cross-Sectional Study.

Authors

  • Neeraj Sinha Author
  • Angad Kumar Author
  • Prabhat Ranjan Author
  • Md Ejaz Alam Author

Keywords:

Type 2 Diabetes Mellitus; Glycated Haemoglobin; HbA1c; Dyslipidaemia; Serum Lipid Profile; Glycaemic Control.

Abstract

Background: Type 2 diabetes mellitus is frequently accompanied by dyslipidaemia, increasing cardiovascular risk. Glycated haemoglobin (HbA1c) reflects long-term glycaemic control, but its relationship with individual lipid parameters varies across studies. This study aimed to assess the association between HbA1c and serum lipid parameters in patients with type 2 diabetes mellitus. Materials and Methods: This hospital-based cross-sectional study was conducted in the Departments of Endocrinology and General Medicine, Patna Medical College and Hospital, from August 2025 to July 2026. This study included 100 patients, categorised into HbA1c <7% and ≥7% groups. Group differences, Pearson correlations and simple linear regression were examined, with p<0.05 considered statistically significant. Results: A total of 100 patients with type 2 diabetes mellitus were included, comprising 48 males (48%) and 52 females (52%). Of these, 45 patients (45%) had HbA1c <7%, while 55 (55%) had HbA1c ≥7%. Patients with HbA1c ≥7% showed higher mean triglyceride levels (172.42 ± 60.90 vs. 132.00 ± 59.50 mg/dL; p = 0.001) and significantly lower HDL-C levels (45.49 ± 10.67 vs. 50.44 ± 10.13 mg/dL; p = 0.020) compared with those with HbA1c <7%. Pearson's correlation analysis demonstrated significant positive correlations of HbA1c with triglycerides (r = 0.349, p < 0.001) and VLDL-C (r = 0.349, p < 0.001), whereas HDL-C showed a significant negative correlation (r = −0.245, p = 0.014). No statistically significant correlations were observed between HbA1c and total cholesterol or LDL-C (p > 0.05). Conclusion: The findings suggest that poorer glycaemic control is associated with higher triglycerides and VLDL-C and lower HDL-C. Concurrent assessment of HbA1c and lipid parameters may support cardiovascular risk evaluation and comprehensive diabetes care. The single-centre, cross-sectional design limits causal inference and generalisability. Confirmation using individual patient records and adjustment for age, sex, body mass index and treatment factors are necessary before journal submission.

References

1. Anjana RM, Unnikrishnan R, Deepa M, Pradeepa R, Tandon N, Das AK, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11(7):474-489. doi:10.1016/S2213-8587(23)00119-5. PMID: 37301218.

2. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-1478. doi:10.2337/dc08-0545. PMID: 18540046.

3. American Diabetes Association Professional Practice Committee for Diabetes. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. Diabetes Care. 2026 Jan 1;49(Supplement_1):S132-S149. doi: 10.2337/dc26-S006. PMID: 41358894; PMCID: PMC12690178.

4. Taskinen MR, Borén J. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis. 2015 Apr;239(2):483-95. doi: 10.1016/j.atherosclerosis.2015.01. 039. Epub 2015 Feb 7. PMID: 25706066.

5. American Diabetes Association Professional Practice Committee for Diabetes. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026. Diabetes Care. 2026 Jan 1;49(Suppl 1):S216-S245. doi: 10.2337/dc26-S010. PMID: 41358899; PMCID: PMC12690187.

6. Sheth J, Shah A, Sheth F, Trivedi S, Nabar N, Shah N, et al. The association of dyslipidemia and obesity with glycated hemoglobin. Clin Diabetes Endocrinol. 2015;1:6. doi:10.1186/s40842-015-0004-6. PMID: 28702225.

7. Kumar A, Keshari JR, Kumar M. Association of glycated hemoglobin and dyslipidemia in patients with type 2 diabetes mellitus in a K.M.C.H. Katihar, Bihar—a retrospective, cross-sectional and descriptive study. Int J Contemp Med. 2021;9(1):35-41. doi:10.37506/ijocm.v9i1.2932.

8. Kumar S, Kumari B, Kaushik A, Banerjee A, Mahto M, Bansal A. Relation between HbA1c and lipid profile among prediabetics, diabetics, and non-diabetics: a hospital-based cross-sectional analysis. Cureus. 2022;14(12):e32909. doi:10.7759/cureus.32909. PMID: 36699757.

9. Lnu P, Lnu J, Banerjee A, Bansal A, Gogoi JB. Lipoprotein ratios: correlations with glycated hemoglobin among type 2 diabetes mellitus patients. Cureus. 2024;16(2):e53665. doi:10.7759/cureus.53665. PMID: 38455822.

10. Uddin MF, Garapati A, Gyanendra KC, Vikram VC, Gangahar A, Chowdary N, et al. Relationship between glycosylated hemoglobin and serum lipid profile in patients with type 2 diabetes mellitus: a cross-sectional analysis. Health Sci Rep. 2025;8(7):e70965. doi:10.1002/hsr2.70965. PMID: 40599411.

11. K P, Kunikullaya U K, Goturu J. Glycosylated Haemoglobin (HbA1c) - A Marker of Circulating Lipids in Type 2 Diabetic Patients. J Clin Diagn Res. 2014 Feb;8(2):20-3. doi: 10.7860/JCDR/2014/7742.3996. Epub 2014 Feb 3. PMID: 24701471; PMCID: PMC3972563.

12. Kumar S. Profile of type 2 diabetes mellitus patients attending family medicine clinic in a rural tribal locality in India. J Family Med Prim Care. 2023 Dec;12(12):3242-3248. doi: 10.4103/jfmpc.jfmpc_2114_22. Epub 2023 Dec 21. PMID: 38361905; PMCID: PMC10866235.

13. AlZeer I, AlBassam AM, AlFeraih A, AlMutairi A, AlAskar B, Aljasser D, et al. Correlation between glycated hemoglobin (HbA1c) levels and lipid profile in patients with type 2 diabetes mellitus at a tertiary hospital in Saudi Arabia. Cureus. 2025;17(3):e80736. doi:10.7759/cureus.80736. PMID: 40242700.

14. Adiels M, Borén J, Caslake MJ, Stewart P, Soro A, Westerbacka J, et al. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol. 2005;25(8):1697-1703. doi:10.1161/01.ATV.0000172689. 53992.25. PMID: 15947244.

15. Hirano T. Pathophysiology of Diabetic Dyslipidemia. J Atheroscler Thromb. 2018 Sep 1;25(9):771-782. doi: 10.5551/jat.RV17023. Epub 2018 Jul 12. PMID: 29998913; PMCID: PMC6143775.

Downloads

Published

2026-11-09

Most read articles by the same author(s)

Similar Articles

41-50 of 80

You may also start an advanced similarity search for this article.